The phosphoinositide 3-kinase (PI3K)/AKT signalling pathway regulates many cellular functions including proliferation, migration, survival and protein synthesis. Somatic mutations in PIK3CA, the gene encoding the p110α catalytic subunit of PI3K enzyme, are commonly associated with many human cancers as well as recently being implicated in human overgrowth syndromes. However, it is not clear if such mutations can be inherited through the germline. We have used a novel mouse model with Cre recombinase (Cre)-conditional knock-in of the common H1047R mutation into the endogenous Pik3ca gene. Heterozygous expression of the
Introduction
The phosphoinositide 3-kinase (PI3K)/AKT signalling pathway regulates processes critical for cell proliferation, growth, migration, survival and angiogenesis [1] . The p110α catalytic subunit of class 1A PI3Ks is encoded by the gene PIK3CA. Somatic mutations within this gene are commonly observed in many human cancers including breast and colon cancers [2, 3] . The majority of PIK3CA mutations cluster at three hot spots within the protein, two in the helical domain (E542 and E545) and one in the kinase domain (H1047), and cause the constitutive activation of the PI3K/Akt signalling pathway (reviewed in [4] ). Interestingly, similar mutations, including the common cancer-associated 'hot spot' mutations, have also recently been observed in overgrowth conditions such as megalencephaly syndromes [5, 6] , fibroadipose hyperplasia [7] and Congenital Lipomatous Overgrowth with Vascular, Epidermal, and Skeletal anomalies (CLOVES) [8] .
Cancer-associated PIK3CA mutations are invariably somatic and PIK3CA-driven overgrowth syndromes are not inherited suggesting that PIK3CA mutations are not compatible with germline transmission. Consistent with this, germline homozygous loss of phosphatase and tensin homolog (Pten), a negative regulator of PI3K, during murine development is fatal before embryonic day (E)11.5 due to vascular abnormalities resulting in bleeding and cardiac failure that arise from aberrant endothelial cell (EC) proliferation [9] .
Interestingly, mice lacking the p110α subunit [10, 11] , or expressing a kinase-dead version of the p110α isoform [12] , are also embryonic lethal, albeit at slightly varying stages of mid-gestation.
Notably, in both cases embryonic lethality is suggested to arise from impaired EC development 3 in which cell migration, proliferation and survival are variably affected. Mice expressing the kinase-dead p110α specifically in ECs demonstrated similar migration and motility defects with lethality occurring before E12.5 [12] . Similarly, the combined ablation of both Akt1 and Akt3 results in embryonic lethality at approximately E11 caused by a decreased vasculature and other cardiovascular defects as well as increased apoptosis in the developing nervous system [13] .
However, Akt1
+/-:Akt2 -/-:Akt3 -/-embryos are able to survive embryogenesis [14] suggesting that Akt1, in particular, is essential for embryogenic development.
These mouse models indicate that tight regulation of PI3K/AKT pathway activity is essential during embryonic development suggesting that mutations which disrupt the normal physiological activity of PIK3CA would be unlikely to be heritable. Nevertheless, germline transmission of PIK3CA mutations has recently been reported in 8 individuals with Cowden or "Cowden-like" syndrome [15] . However, the reported mutations are not within known oncogenic 'hot spot' regions in the PIK3CA gene.
In order to determine if the cancer-causing PIK3CA 'hot spot' mutations can indeed be transmitted through the germline, we have used a mouse model with a Cre recombinase (Cre)-conditional knock-in of the common cancer-associated H1047R mutation into the endogenous Pik3ca gene [16] [17] [18] . We show that both ubiquitous and EC-specific expression of the Pik3ca H1047R mutation during embryonic development leads to severe vascular malformations that result in lethality prior to E10.5.
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Materials and Methods

Generation of mice Pik3ca
Lat-H1047R mice, generated as previously described [16] , were mated to either Cre-deleter (B6.C-Tg(CMV-cre)1Cgn/J) transgenic mice which ubiquitously express Cre recombinase (Cre)
from the zygote stage of development [19] or Tie2Cre (B6.Cg-Tg(Tek-cre)1Ywa/J) transgenic mice whose Cre expression is under the control of the EC-specific Tie2 promoter [20] . All mice strains were maintained on the C57BL/6 background. Blastocysts were collected at E3.5 as previously described [22] . Briefly, Cre-del female mice were injected with 5 i.u. of pregnant mare's serum gonadotropin (PMS: Folligon, Intervet) followed by 2.5 i.u. of human chorionic gonadotropin (hCG: Chorulon, Intervet) 48 hours later, to stimulate ovulation. This was followed by overnight mating with a male Pik3ca
Lat-H1047R/WT mouse. Two days later, pregnant females were culled and E2.5 morula collected and placed in culture overnight at 6% CO 2 in Cooks blastocyst media (Cook Medical, Australia) before DNA was extracted from individual E3.5 embryos for genotyping.
Embryos were obtained from timed matings with the day of the detection of a vaginal plug considered as E0.5. Embryos and yolk sacs between E8.5 and E14.5 were isolated as previously described [23] . Yolk sacs were taken for DNA isolation and genotyping when possible.
Alternatively, when yolk sacs were required, embryo tails were used for genotyping.
PCR genotyping of embryos
Embryo tails or yolk sacs were placed in cell lysis buffer consisting of 50mM Tris pH 8.8, 10 mM (NH 4 )SO 4 , 6.5 mM MgCl 2 , 0.5% Triton X-100 and 1% β-mercaptoethanol (200 μL for E10-14.5, 100 μL for E8-9.5 and 20 μL for E3.5 embryos) and proteinase-K added to a final concentration of 150 μg/mL. Following overnight incubation at 55°C, samples were heated to 95°C for 15 minutes, mixed well and centrifuged at 13,000 rpm for 5 minutes. The primers for analysis of Cre and Pik3ca genotypes, and PCR conditions for each reaction, were as previously described [16] .
Immunofluorescence and LacZ staining 6 Freshly isolated embryos and yolk sacs were fixed in cold 4% paraformaldehyde at 4°C for 2 At E8.5, mutant embryos were indistinguishable to controls with similar numbers of somites and overall size ( Figure 1A ). Strikingly, compared to littermate controls ( Figure 1A-F 
Cardiovascular and angiogenic defects are observed in Cre-deleter:Pik3ca H1047R embryos
The onset of blood flow through the cardiovascular system at E8.5-10 is a critical developmental event to provide oxygen and nutrients to the growing embryo. As this is the time at which embryonic lethality is observed in the Cre-del:Pik3ca H1047R heterozygous mutant mice, we Remodelling of the primitive vascular network into a higher order complex of arteries, veins and arterioles is an essential process for the correct function of the cardiovascular system, and is thought to be dependent, in part, on haemodynamic forces produced by blood flow [24] . As Credel:Pik3ca H1047R mutants had pronounced angiogenic defects and were deficient in blood flow we next asked if the major vessels had become specified. Using antibodies to Nrp1 and Nrp2 that preferentially label either arteries or veins, respectively, we found that vessels failed to remodel in mutant embryos. Thus, in comparison to controls, Nrp1 did not label arterial vessels of the dorsal aorta or the pharyngeal arch arteries (inset and marked by ∆ respectively in Figure 2B ), and Nrp2 did not label the anterior cardinal vein in the mutant embryos (inset, Figure 2C ).
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Extraembryonic vessel remodelling defects observed as a result of mutant Pik3ca
H1047R expression
Previous work has suggested that defects in vessel formation (or function) and blood formation in extraembryonic tissues may cause death in developing embryos. In comparison to control embryos, the yolk sacs from E9.5 Cre-del:Pik3ca H1047R embryos were pale, wrinkled, lacked visible blood-filled vitelline vessels ( Figure 3A ), and possessed endothelial lined 'lacunae'
(white arrows, Figure 3B ).
Staining of whole yolk sacs with vascular markers such as VEGFR2 and CD31 clearly demonstrate the complex network of vessels formed in the controls (top panel, Figure 3C and Supplementary figure 3). In contrast, mutant yolk sacs lacked remodelling of the vasculature into a complex ordered network with rare regions of avascular space (white arrows, lower panel, Figure 3C and Supplementary figure 3). We next analysed proliferation and apoptosis in E9.5
Cre-del:Pik3ca H1047R yolk sacs using antibodies to phosphorylated histone H3 (PHH3) and activated caspase 3, respectively. Although no notable differences in apoptosis were identified, a striking increase in proliferating cells in Cre-del:Pik3ca H1047R yolk sacs was observed, consistent with previous reports showing that the Pik3ca H1047R mutation leads to constitutive PI3K activation and proliferation [25] [26] [27] . Transverse sections of the yolk sacs further confirmed the lack of vascular remodelling with dramatically increased space between the extraembryonic endoderm and mesoderm in the mutants compared to controls ( Figure 3D ). Microscopic analysis also confirmed fewer blood cells (indicated by arrowheads) within the mutant yolk sacs ( Figure   3D ).
We next assessed embryos at E8.5. Early vessel formation within both control and mutant embryos progressed normally with obvious formation of the paired dorsal aorta ( Figure 4A ). In contrast, striking defects were evident in the yolk sacs of E8. Figure 4A ). Staining of yolk sac sections with VEGFR2 and eosin clearly shows blood islands have formed in the Cre-del:Pik3ca H1047R yolk sacs but with fewer blood cells present and vacuole space much larger than controls (indicated by black and white bars, Figure   4B ).
Taken together, these findings show that mesodermal precursors have differentiated into endothelial cells and condensed into a primitive vascular network in mutant embryos, but that the process of angiogenesis and vascular remodeling is compromised. Our data further suggest that the major vascular defects occur during vessel remodelling which in turn leads to compromised blood flow and embryonic death.
Constitutive PI3K/Akt signalling by the Pik3ca H1047R mutation affects VEGF expression
Development of the vasculature is heavily dependent on vascular endothelial growth factor A (VEGF-A) signalling (reviewed in [28]). As PI3K acts as a positive effector of VEGF levels, we profiled the mRNA expression of important members of the VEGF signalling pathway in E9.5
Cre-del:Pik3ca H1047R embryos and yolk sacs by RT-PCR ( Figure 5 ). Expression of Vegf-A,
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Vegfr2 and Nrp2 were significantly increased in the Cre-del:Pik3ca H1047R mutant embryonic tissues ( Figure 5A , D and J). In contrast, only Nrp1 was significantly increased in the yolk sacs of Cre-del:Pik3ca H1047R mutants ( Figure 5K ). There was also a general trend for all assessed VEGF signalling factors to be up-regulated in the Pik3ca H1047R mutant tissues suggesting constitutive PI3K/Akt signalling as a result of the Pik3ca H1047R mutation increases activity of the VEGF pathway during early development of both the intra and extraembryonic tissues. in the embryo and, to a lesser extent, in the yolk sac ( Figure 5L -M), which is possibly contributing to the vessel remodelling and maturation defects.
Expression of the Pik3ca H1047R mutation in endothelial cells causes lethality by E11.5
As the ubiquitously expressed Pik3ca H1047R mutation had pronounced effects on vessel development, we sought to determine if this was under the control of cell autonomous changes in endothelial cells. To specifically target the mutation to endothelial cells we crossed Pik3ca
Lat-H1047R mice to the Tie2Cre mouse strain in which Cre expression is restricted to the developing vascular system (Supplementary figure 1) . No Tie2Cre
pups were born and analysis of embryos at various time points revealed lethality was occurring prior to E11.5 (Table 3) . Morphological analysis at E9.5 showed that, unlike the Credel:Pik3ca H1047R embryos, Tie2Cre:Pik3ca H1047R embryos had undergone the turning process and had normal patterning of the anterior-posterior axis, although overall growth was retarded ( Figure 6A ).
At E10.5, Tie2Cre:Pik3ca H1047R mutant embryos were significantly smaller and developmentally delayed compared to wild type littermates and were comparable in size to mutant embryos at E9.5 ( Figure 6A ). While E9.5 Tie2Cre:Pik3ca H1047R mutant embryos were observed to have a heartbeat, few E10.5 mutant embryos displayed a heartbeat and, in those that did, the contractions were significantly slower and less frequent. Together, this suggests the mutant embryos had stopped developing and tissue autolysis had begun at E10.5. Blood flow was deficient in mutant embryos at E9.5, while at E10.5 both the mutant yolk sac and embryo had reduced blood accumulations suggesting that primitive haematopoiesis is affected by the Pik3ca H1047R mutation. Transverse sections through the pharyngeal arch territory were stained for endomucin. While the dorsal aorta and anterior cardinal vein could be detected in all mutants there was an overall decrease in vascular density in the Tie2Cre:Pik3ca H1047R embryos compared to controls ( Figure   7A and B). At E9.5, arterial and venous specification was also absent in Tie2Cre:Pik3ca Figure   8C ). Eosin staining of yolk sac sections clearly demonstrates fewer blood cells in the Tie2Cre:Pik3ca H1047R mutants with a lack of distinct blood islands and widening of the blood vessels (right panel, Figure 8C ). 
Cardiac and vascular defects observed in Tie2Cre specific
Discussion
We have used a novel mouse model with a Cre-conditional heterozygous knock-in of the Pik3ca H1047R mutation to examine the consequences of germline transmission of this genetic defect. As the mutation is knocked into the endogenous gene, expression is under the control of the endogenous Pik3ca promoter and thus the mutant protein is only expressed by cells that normally express Pik3ca and at normal physiological levels.
Using the Cre-deleter model to induce ubiquitous expression of the mutation from the earliest stages of embryogenesis we demonstrate that the Pik3ca H1047R mutation is lethal by E10.5. This lethality likely occurs at multiple levels. Restricting the expression of the mutation specifically to ECs using the Tie2-Cre model resulted in severe vascular defects and embryonic death.
However, in this case, death occurred a day later (at E11. embryos are observed beyond E7.5 [30, 9] , while removal of Pten in endothelial cells resulted in embryonic lethality before E11.5 due to bleeding and cardiac failure caused by the failure of vessels to recruit mural cells to support the vascular wall [9] . Interestingly, both ubiquitous knockout of Pik3ca [11] and ubiquitous or EC-specific expression of a kinase-dead Pik3ca allele [12] have also been reported to cause embryonic lethality at mid-gestation due to severe vascular defects. Taken together with our own data, these findings demonstrate that while p110α, the protein product of the Pik3ca gene, is essential for embryogenesis, tight control of its activity is vital for normal embryonic development.
Development of the blood vasculature system during embryogenesis involves a complex and intricate series of biological processes that rely on controlled expression of many signalling pathways, including the VEGF and PI3K/AKT pathways. Here we demonstrate that ubiquitous and EC-targeted expression of the Pik3ca H1047R mutation causes dramatic embryonic and extraembryonic vascular defects. Whereas the formation of vessels from mesodermal precursors (vasculogenesis) was clearly observed in mutant embryos and yolk sacs, the primitive vasculature failed to remodel resulting in embryonic lethality. The dramatic vascular remodelling defects and enlargement of vessels observed in the yolk sacs of both the ubiquitous and EC specific mutants at E9.5 provide a likely explanation to the reduced haemodynamic force within 18 the embryo that in turn leads to embryonic vascular defects and embryonic lethality. Our data further fit with the notion that the vascular defects arise as a result of aberrant proliferation, a finding that is in agreement with previous studies investigating oncogenic PI3K mutations in vivo [16, 17] . In addition to EC hyperproliferation, our data also suggest that VEGF-mediated hyperfusion may also play a role in the development of enlarged vessels in the yolk sacs of Pik3ca H1047R mutants. Indeed, mice over expressing VEGF to a similar degree as reported here have similar vessel defects in the yolk sacs that result from aberrant fusion of the primitive blood vessels [31, 32] .
VEGF-A was originally discovered as an inducer of vascular permeability [33] and is considered the most potent growth factor in vessel development. There are several transgenic Vegf-A mice which all vary in their expression levels. Mice which are heterozygous null for Vegf-A (Vegf-A +/ )
are embryonically lethal at E11-12 due to failed vascular development [34, 35] while homozygous null mice are lethal earlier with severe vascular and hematopoietic defects [34] .
Interestingly, it has also been observed that mice with moderate overexpression of Vegf-A are also embryonically lethal at E12.5-14 due to severe cardiovascular defects [36] . Significantly, this demonstrates the critical role of well-regulated Vegf-A signalling during mouse development similar to that which we have demonstrated is critical for PI3K/Akt signalling.
Our results demonstrate an essential role for finely-tuned PI3K activation to control expression of VEGF and other members of the VEGF signalling pathway. We identified a greater than 5
fold increase in VEGF levels in embryos expressing the Pik3ca H1047R mutation. In addition, increased expression of the VEGF receptors Nrp1, Nrp2 and VEGFR2 was also identified. Given the requirement of tightly regulated VEGF signalling in vascular development these findings offer a likely explanation for the profound vascular defects and the embryonic lethality observed in the Pik3ca H1047R mutant embryos. However, the lack of Nrp1 and Nrp2 protein expression specifically in the vessels of the mutant embryos (Fig. 2) suggests that the more global increases in expression of these genes detected in mRNA extracted from whole embryos (Fig. 5 ) may be related to their role in neuronal, neural crest and somitic development [37, 38] that also occurs at this point in development.
Our observation that Pik3ca H1047R and Tie2Cre:Pik3ca H1047R mutant embryos had reduced blood cells within the embryo and yolk sac was unexpected as the PI3K signalling pathway has not previously been implicated in primitive hematopoesis. At E8.5 VEGFR2 and eosin staining identified numerous blood islands and blood cells scattered throughout the yolk sac of both mouse lines, however, by E9.5 mutant embryos had a dramatic reduction in blood cells. As Tie2 also drives Cre expression in the primitive angioblast, future studies would benefit from investigating if this reduced number of erythrocytes results from a primary role of PI3K in hemangiogenesis and hematopoesis or if this reduction is secondary to aberrant blood vessel / blood island development.
Our data suggest that activating mutations in the PIK3CA gene are not compatible with germline transmission. Indeed, there is only a single report of germline PIK3CA mutations, in 8 individuals with Cowden or "Cowden-like" syndrome [15] . However, apart from 2 patients both with dual c.16344 A>C and c.1658_1659 delGTinsC changes (that are identical to the known sequence of the PIK3CA pseudogene found on human chromosome 22q11.2 [39, 40] ), the 20 reported mutations are not within known oncogenic 'hot spot' regions in the PIK3CA gene and MutPred software used to predict the functionality of germline mutations predicts them to be benign variations [15] .
Consistent with the lack of germline PIK3CA mutations in cancer patients, PIK3CA mutations recently reported to be responsible for a variety of segmental overgrowth syndromes, including CLOVES, hemimegaencephaly and fibroadipose hyperplasia (FH), are acquired post-zygotically and are not inherited [5, 7, 8, 6, 41] . Interestingly, individuals with these overgrowth conditions have been observed to have vascular malformations including capillary venous and/or lymphatic malformations [8] . Patterning defects are also observed in a large number of these individuals and polydactyly or syndactyly in the hands and or feet is seen in most cases [8, 41] . Such vascular and patterning defects are consistent with the phenotypes observed here when Pik3ca H1047R is ubiquitously expressed during embryogenesis.
Our results add to the growing body of work highlighting the essential role of the PI3K pathway in vascular development and demonstrate an essential requirement for tight regulatory control over PI3K activity during embryonic development. The lethality associated with heterozygous expression of the Pik3ca H1047R mutation during development likely explains the lack of inherited germline PIK3CA mutations in humans. ) (F) were as controls for β-Gal staining. Scale bars, 500μm.
